- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT01375088
Assessing the Preventing and Therapeutic Effect of Propolis in Radiotherapy Induced Mucositis of Head and Neck Cancers
November 21, 2012 updated by: ATESSA PAKFETRAT, Mashhad University of Medical Sciences
Phase I Assessing the Preventing and Therapeutic Effect of Propolis in Radiotherapy Induced Mucositis of Head and Neck Cancers
The purpose of this study is to determine whether propolis is effective in the treatment and prevention of radiotherapy induced oral mucositis.
Study Overview
Status
Completed
Intervention / Treatment
Detailed Description
Patients with head and neck malignancy with inclusion criteria randomly divide in 2 groups and take the intervention.
Study Type
Interventional
Enrollment (Actual)
20
Phase
- Phase 2
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Khorasan Razavi
-
Mashhad, Khorasan Razavi, Iran, Islamic Republic of
- Mashhad University of Medical Science
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
15 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria: - age >15
- need of radiotherapy
- at least half of the mouth in the field of radiation
- dose 50 -70 Gy
- head & neck malignancy
Exclusion Criteria:
- systemic disease
- FBS > 150 WBC > 3000
- history of radiotherapy
- need of chemotherapy
- systemic disease
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Triple
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
Placebo Comparator: placebo mouth wash
10 patients swish & swallow 15 ml placebo mouth wash for at least 5 min from the first session of radiotherapy until the last session
|
15 ml mouth wash 3 times a day for the whole period of radiotherapy for 5 min swish and then swallow
|
Active Comparator: propolis
10 patients swish & swallow 15 ml propolis mouth wash for at least 5 min from the first session of radiotherapy until the last session
|
15 ml mouth wash 3 times a day for the whole period of radiotherapy for 5 min swish and then swallow
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
NCI.CTC Scale
Time Frame: 9 month
|
we use NCI-CTC scale for patients in 2 groups to assess effect of propolis mouth wash on prevention and treatment of mucositis in patients under radiotherapy.We measured signs(size and sypmtoms) of mucositis by NCI-CTC scale and also we assessed the onset of the mucositis to describe the prevention efficacy of propolis.
|
9 month
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
hyposalivation scale
Time Frame: 9 month
|
we use a scale for patients in 2 groups to assess effect of propolis maouth wash on subjective xerostomy and signs of candidiasis in patiants under radiotherapy
|
9 month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Principal Investigator: arghavan tonkaboni, resident, oral medicine dep, dental school, mashhad university of medical science
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
October 1, 2010
Primary Completion (Actual)
March 1, 2011
Study Completion (Actual)
May 1, 2011
Study Registration Dates
First Submitted
June 1, 2011
First Submitted That Met QC Criteria
June 16, 2011
First Posted (Estimate)
June 17, 2011
Study Record Updates
Last Update Posted (Estimate)
November 22, 2012
Last Update Submitted That Met QC Criteria
November 21, 2012
Last Verified
November 1, 2012
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- 339888
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Radiation-induced Mucositis of Oral Mucous Membranes
-
Salma Hesham ElhoufiRecruitingOral Mucositis (Ulcerative) Due to Radiation | Radiation-Induced Mucositis | Radiation MucositisEgypt
-
Galera Therapeutics, Inc.CompletedRadiation Induced Oral MucositisUnited States, Canada, Puerto Rico
-
Solasia Pharma K.K.Solasia Medical Information Consulting (Shanghai) Co. Ltd.CompletedChemotherapy- and/or Radiation-induced Oral MucositisChina
-
Stephen E. FeinbergTerminatedDisorder of Oral Mucous MembraneUnited States
-
University Hospital Schleswig-HolsteinUnknownRadiation Dermatitis | Radiation-induced Oral MucositisGermany, Spain
-
Shanxi Zhendong Pharmacy Co., LtdRecruitingRadiation-induced Oral MucositisChina
-
Hams Hamed AbdelrahmanUnknownOral Mucositis Due to RadiationEgypt
-
Bitop AGCompletedOral Mucositis Due to RadiationHungary
-
NeoMedLightQualissimaCompletedRadiation Dermatitis | Oral Mucositis Due to RadiationFrance
-
Lannett Company, Inc.TerminatedDiagnostic | Procedures and Surgeries on or Through Accessible Mucous Membranes | of the Nasal CavitiesUnited States
Clinical Trials on propolis
-
Universidade Federal do ParaCompleted
-
Taipei Medical UniversityUnknownOral MucositisTaiwan
-
University of TalcaHospital Regional de TalcaCompletedDiabetes Mellitus, Type 2
-
Federal University of Minas GeraisCoordenação de Aperfeiçoamento de Pessoal de Nível Superior.; Conselho Nacional...CompletedStreptococcal Infections | Saliva Altered
-
Shanghai Greenvalley Pharmaceutical Co., Ltd.CompletedStable Angina PectorisChina
-
Nourhan M.AlyAlexandria UniversityCompletedEarly Childhood CariesEgypt
-
Trabzon Kanuni Education and Research HospitalActive, not recruiting
-
University of Sao Paulo General HospitalHospital Sao Rafael; Alagoas State University of Health Science , Maceió ,...CompletedChronic Kidney Disease Requiring Chronic DialysisBrazil
-
Federal University of Minas GeraisConselho Nacional de Desenvolvimento Científico e Tecnológico; Fundação de...CompletedGingivitis | Dental PlaqueBrazil
-
Taipei Medical UniversityNot yet recruitingOral Mucositis | Microbiota | Symptoms and Signs